BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

765 related articles for article (PubMed ID: 25935309)

  • 1. Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2.
    Wang H; Lai Y; Mathis BJ; Wang W; Li S; Qu C; Li B; Shao L; Song H; Janicki JS; Sun SC; Wang XL; Tang D; Cui T
    J Mol Cell Cardiol; 2015 Jul; 84():143-53. PubMed ID: 25935309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nrf2-Mediated Cardiac Maladaptive Remodeling and Dysfunction in a Setting of Autophagy Insufficiency.
    Qin Q; Qu C; Niu T; Zang H; Qi L; Lyu L; Wang X; Nagarkatti M; Nagarkatti P; Janicki JS; Wang XL; Cui T
    Hypertension; 2016 Jan; 67(1):107-17. PubMed ID: 26573705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nrf2 protects against maladaptive cardiac responses to hemodynamic stress.
    Li J; Ichikawa T; Villacorta L; Janicki JS; Brower GL; Yamamoto M; Cui T
    Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1843-50. PubMed ID: 19592468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nrf2 enhances myocardial clearance of toxic ubiquitinated proteins.
    Wang W; Li S; Wang H; Li B; Shao L; Lai Y; Horvath G; Wang Q; Yamamoto M; Janicki JS; Wang XL; Tang D; Cui T
    J Mol Cell Cardiol; 2014 Jul; 72():305-15. PubMed ID: 24747945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Pathological Cardiac Hypertrophy.
    He B; Zhao YC; Gao LC; Ying XY; Xu LW; Su YY; Ji QQ; Lin N; Pu J
    Hypertension; 2016 Jun; 67(6):1237-48. PubMed ID: 27045030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYLD exaggerates pressure overload-induced cardiomyopathy via suppressing autolysosome efflux in cardiomyocytes.
    Qi L; Zang H; Wu W; Nagarkatti P; Nagarkatti M; Liu Q; Robbins J; Wang X; Cui T
    J Mol Cell Cardiol; 2020 Aug; 145():59-73. PubMed ID: 32553594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulator of G-Protein Signaling 10 Negatively Regulates Cardiac Remodeling by Blocking Mitogen-Activated Protein Kinase-Extracellular Signal-Regulated Protein Kinase 1/2 Signaling.
    Miao R; Lu Y; Xing X; Li Y; Huang Z; Zhong H; Huang Y; Chen AF; Tang X; Li H; Cai J; Yuan H
    Hypertension; 2016 Jan; 67(1):86-98. PubMed ID: 26573707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triterpenoid dihydro-CDDO-trifluoroethyl amide protects against maladaptive cardiac remodeling and dysfunction in mice: a critical role of Nrf2.
    Xing Y; Niu T; Wang W; Li J; Li S; Janicki JS; Ruiz S; Meyer CJ; Wang XL; Tang D; Zhao Y; Cui T
    PLoS One; 2012; 7(9):e44899. PubMed ID: 23028668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raf kinase inhibitor protein mediates myocardial fibrosis under conditions of enhanced myocardial oxidative stress.
    Kazakov A; Hall RA; Werner C; Meier T; Trouvain A; Rodionycheva S; Nickel A; Lammert F; Maack C; Böhm M; Laufs U
    Basic Res Cardiol; 2018 Sep; 113(6):42. PubMed ID: 30191336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
    Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
    Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
    Suzuki K; Satoh K; Ikeda S; Sunamura S; Otsuki T; Satoh T; Kikuchi N; Omura J; Kurosawa R; Nogi M; Numano K; Sugimura K; Aoki T; Tatebe S; Miyata S; Mukherjee R; Spinale FG; Kadomatsu K; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):636-46. PubMed ID: 26916734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
    Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
    J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Protective Role for Ubiquitin-Specific Protease 18 in Pathological Cardiac Remodeling.
    Ying X; Zhao Y; Yao T; Yuan A; Xu L; Gao L; Ding S; Ding H; Pu J; He B
    Hypertension; 2016 Nov; 68(5):1160-1170. PubMed ID: 27572150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell antigen 1 protects against cardiac hypertrophy and fibrosis after pressure overload.
    Zhou H; Bian ZY; Zong J; Deng W; Yan L; Shen DF; Guo H; Dai J; Yuan Y; Zhang R; Lin YF; Hu X; Li H; Tang QZ
    Hypertension; 2012 Sep; 60(3):802-9. PubMed ID: 22851736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy.
    Sopontammarak S; Aliharoob A; Ocampo C; Arcilla RA; Gupta MP; Gupta M
    Cell Biochem Biophys; 2005; 43(1):61-76. PubMed ID: 16043884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo cardiac role of migfilin during experimental pressure overload.
    Haubner BJ; Moik D; Schuetz T; Reiner MF; Voelkl JG; Streil K; Bader K; Zhao L; Scheu C; Mair J; Pachinger O; Metzler B
    Cardiovasc Res; 2015 Jun; 106(3):398-407. PubMed ID: 25852081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation.
    Hamid T; Gu Y; Ortines RV; Bhattacharya C; Wang G; Xuan YT; Prabhu SD
    Circulation; 2009 Mar; 119(10):1386-97. PubMed ID: 19255345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nrf2 Activation as a Protective Feedback to Limit Cell Death in High Glucose-Exposed Cardiomyocytes.
    Tsai CY; Wen SY; Cheng SY; Wang CH; Yang YC; Viswanadha VP; Huang CY; Kuo WW
    J Cell Biochem; 2017 Jul; 118(7):1659-1669. PubMed ID: 27859591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
    Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
    J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.